Education
About Us
Working with TipRanks
Follow Us
Beamtree Holdings Ltd (AU:BMT)
ASX:BMT
BMT Stock Chart & Stats
AU$0.22
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.22
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.13 - AU$0.33
Previous CloseN/A
Volume9.49K
Average Volume (3M)122.51K
Market Cap
AU$43.60M
Enterprise ValueAU$44.30M
Total Cash (Recent Filing)AU$2.94M
Total Debt (Recent Filing)AU$3.65M
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding290,643,220
10 Day Avg. Volume152,204
30 Day Avg. Volume122,509
Financial Highlights & Ratios
PEG Ratio-0.66
Price to Book (P/B)1.72
Price to Sales (P/S)2.53
P/FCF Ratio-39.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.30Price Target Upside36.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.01
Revenue Forecast (FY)AU$31.40M
Bulls Say, Bears Say
Bulls Say
High Gross MarginAn observed 100% gross profit margin indicates the core product has minimal direct costs, implying a highly scalable software/data business. If revenue growth resumes, this margin profile can translate to strong operating leverage and long-term margin expansion once fixed costs are absorbed.
Conservative Balance SheetThe balance sheet displays relatively low leverage and a stable equity ratio, offering financial flexibility. Conservative capital structure provides a cushion to fund product development or absorb operating losses, important given long sales cycles in healthcare IT.
Specialized Healthcare Data PlatformBeamtree's niche focus on clinical terminology, coding and decision support creates high switching costs and deep workflow integration. Structural digitization in hospitals and growth in analytics/quality documentation support durable demand for specialized clinical data platforms.
Bears Say
Negative Operating ProfitabilityNegative EBIT and EBITDA margins show the company remains unprofitable at the operating level. Persistent operating losses erode equity and constrain reinvestment; without sustained revenue improvement or material cost reductions, recovering durable profitability will be difficult.
Weak Cash GenerationNegative free cash flow growth and weak operating cash conversion point to liquidity strain. Poor cash generation can force dilutive financing or restrict investment in sales and product development, hindering the company’s ability to scale and compete over the medium term.
Revenue Growth DeclineReported revenue growth turning negative suggests weakening demand or competitive pressure. Declining top-line reduces ability to leverage fixed costs and fund growth initiatives, raising the risk that operating losses persist and long-term market position erodes.
Beamtree Holdings Ltd News
BMT FAQ
What was Beamtree Holdings Ltd’s price range in the past 12 months?
Beamtree Holdings Ltd lowest share price was AU$0.13 and its highest was AU$0.33 in the past 12 months.
What is Beamtree Holdings Ltd’s market cap?
Beamtree Holdings Ltd’s market cap is AU$43.60M.
When is Beamtree Holdings Ltd’s upcoming earnings report date?
Beamtree Holdings Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 163 days.
How were Beamtree Holdings Ltd’s earnings last quarter?
Beamtree Holdings Ltd released its earnings results on Feb 18, 2026. The company reported -AU$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.01.
Is Beamtree Holdings Ltd overvalued?
According to Wall Street analysts Beamtree Holdings Ltd’s price is currently Undervalued.
Does Beamtree Holdings Ltd pay dividends?
Beamtree Holdings Ltd does not currently pay dividends.
What is Beamtree Holdings Ltd’s EPS estimate?
Beamtree Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beamtree Holdings Ltd have?
Beamtree Holdings Ltd has 290,643,220 shares outstanding.
What happened to Beamtree Holdings Ltd’s price movement after its last earnings report?
Beamtree Holdings Ltd reported an EPS of -AU$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Beamtree Holdings Ltd?
Currently, no hedge funds are holding shares in AU:BMT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beamtree Holdings Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.30 (36.36% Upside)
AU$0.30 (36.36% Upside)
Blogger Sentiment
Bullish
AU:BMT Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.00%
12-Months-Change
Fundamentals
Return on Equity
-14.19%
Trailing 12-Months
Asset Growth
-5.78%
Trailing 12-Months
Company Description
Beamtree Holdings Ltd
Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a coding quality assessment tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data. It also provides RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; and Codexpert, a searchable eBook application that offers classification reference information for clinical coding patient records. The company offers advisory and auditing solution, such as desktop analysis, data maturity index, and physical audits. It serves customers through channel partners. The company was formerly known as PKS Holdings Limited and changed its name to Beamtree Holdings Limited in August 2021. Beamtree Holdings Limited was founded in 1996 and is headquartered in Redfern, Australia.
BMT Stock 12 Month Forecast
Average Price Target
AU$0.30
▲(36.36% Upside)
Technical Analysis
Mach7 Technologies
―
Resonance Health Ltd
―
―
Alcidion Group Limited
―
PainChek Ltd
―
Options Prices
Currently, No data available
---